The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. An immunopathologic study

Management of Non-Epithelial Ovarian Tumours

“…Two types of MMT are recognised, homologous MMT where the mesenchymal or sarcomatous element is indigenous to the ovary, such as leiomyosarcoma, fibrosarcoma or angiosarcoma and heterologous MMT where the mesenchymal component is foreign such as rhabdomyosarcoma, liposarcoma or chondrosarcoma. There is debate as to the sarcomatous or carcinomatous histiogenesis of MMT and consequently whether platinum- or anthracycline-based chemotherapy would be more effective [42]. The majority of women who present with MMT are postmenopausal with a median age at diagnosis of 66–69 years.…”

Management of Non-Epithelial Ovarian Tumours

“…Two types of MMT are recognised, homologous MMT where the mesenchymal or sarcomatous element is indigenous to the ovary, such as leiomyosarcoma, fibrosarcoma or angiosarcoma and heterologous MMT where the mesenchymal component is foreign such as rhabdomyosarcoma, liposarcoma or chondrosarcoma. There is debate as to the sarcomatous or carcinomatous histiogenesis of MMT and consequently whether platinum- or anthracycline-based chemotherapy would be more effective [42]. The majority of women who present with MMT are postmenopausal with a median age at diagnosis of 66–69 years.…”

Management of Non-Epithelial Ovarian Tumours

“…Two types of MMT are recognised, homologous MMT where the mesenchymal or sarcomatous element is indigenous to the ovary, such as leiomyosarcoma, fibrosarcoma or angiosarcoma and heterologous MMT where the mesenchymal component is foreign such as rhabdomyosarcoma, liposarcoma or chondrosarcoma. There is debate as to the sarcomatous or carcinomatous histiogenesis of MMT and consequently whether platinum- or anthracycline-based chemotherapy would be more effective [42]. The majority of women who present with MMT are postmenopausal with a median age at diagnosis of 66–69 years.…”

Management of Non-Epithelial Ovarian Tumours

“…Two types of MMT are recognised, homologous MMT where the mesenchymal or sarcomatous element is indigenous to the ovary, such as leiomyosarcoma, fibrosarcoma or angiosarcoma and heterologous MMT where the mesenchymal component is foreign such as rhabdomyosarcoma, liposarcoma or chondrosarcoma. There is debate as to the sarcomatous or carcinomatous histiogenesis of MMT and consequently whether platinum- or anthracycline-based chemotherapy would be more effective [42]. The majority of women who present with MMT are postmenopausal with a median age at diagnosis of 66–69 years.…”